+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antiseptic and Disinfectant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • PDF Icon

    Report

  • 210 Pages
  • June 2018
  • Region: Global
  • Transparency Market Research
  • ID: 4852012

Antiseptic and Disinfectant Market - Overview



This report on the antiseptic and disinfectant market analyzes the current and future scenario of the global market. Large number of hospital acquired infections and wound care therapy among the geriatric population after surgery is increasing the usage of antiseptic and disinfectant. Less pain and high definition in eliminating infectious organisms are major drivers of the global antiseptic and disinfectant market.



The antiseptic and disinfectant market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, end-user and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises product portfolios of major players, based on constituents & application, in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis by key players. Thus, presenting a thorough analysis of the overall competitive scenario in the global antiseptic and disinfectant market.



Based on product, the market has been segmented into quaternary ammonium compounds, chlorine compounds, alcohols, aldehydes, phenolic compounds, hydrogen peroxide, iodine, silver, and others. The product segment has been analyzed based on available approved products, cost-effectiveness, and preference for sterilization process by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.



Based on end-user, the antiseptic and disinfectant market has been segmented into healthcare providers (life sciences industry, hospitals, pharmaceutical, etc.), commercial users (hospitality and hotel industry, public hygiene, industries, etc.), and domestic users (household, research, etc.). The market segments have been extensively analyzed based on prevalence of the diseases and usage of antiseptics & disinfectants during available treatment and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the period from 2018 to 2026, considering 2017 as the base year.



In terms of geography, the global antiseptic and disinfectant market has been categorized into five major regions and the key countries in the respective region are: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.



The report also profiles major players in the global antiseptic and disinfectant market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, Cardinal Health, Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.


Table of Contents

Chapter 1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2.Assumptions and Research MethodologyChapter 3.Executive Summary : Global Antiseptic and Disinfectant Market
Chapter 4.Market Overview
4.1. Introduction
4.1.1. Modality Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Antiseptic and Disinfectant Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.6. Market Outlook
4.7.Regulatory Scenarios
4.8. Distributor Analysis - by Company
4.9. List of Manufacturers (Classified by Disinfectants Production Capabilities)
4.9.1. High Level
4.9.2. Low Level
4.9.3. Middle Level
4.10. Pricing Comparison Analysis
4.10.1. By Product
4.10.2. By Company
Chapter 5.Global Antiseptic and Disinfectant Market Analysis and Forecast, by Product
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Market Value Forecast by Product, 2016-2026
5.3.1. Quaternary Ammonium Compounds
5.3.2. Chlorine Compounds
5.3.3. Alcohols
5.3.4. Aldehydes
5.3.5. Phenolic Compounds
5.3.6. Hydrogen Peroxide
5.3.7. Iodine
5.3.8. Silver
5.3.9. Others
5.4. Market Attractiveness by Product
Chapter 6.Global Antiseptic and Disinfectant Market Analysis and Forecast, by End-user
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast by End-user, 2016-2026
6.3.1. Healthcare Providers
6.3.2. Commercial Users
6.3.3. Domestic Users
6.4. Market Attractiveness by End-user
Chapter 7.Global Antiseptic and Disinfectant Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness, by Country/Region
Chapter 8.North America Antiseptic and Disinfectant Market Analysis and Forecast
8.1.Introduction
8.1.1. Key Findings
8.2.Market Value Forecast, by Product, 2016-2026
8.2.1. Quaternary Ammonium Compounds
8.2.2. Chlorine Compounds
8.2.3. Alcohols
8.2.4. Aldehydes
8.2.5. Phenolic Compounds
8.2.6. Hydrogen Peroxide
8.2.7. Iodine
8.2.8. Silver
8.2.9. Others
8.3.Market Value Forecast, by End-user, 2016-2026
8.3.1. Healthcare Providers
8.3.2. Commercial Users
8.3.3. Domestic Users
8.4.Market Value Forecast, by Country, 2016-2026
8.4.1. U.S.
8.4.2. Canada
8.5.Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By End-user
8.5.3. By Country
Chapter 9.Europe Antiseptic and Disinfectant Market Analysis and Forecast
9.1.Introduction
9.1.1. Key Findings
9.2.Market Value Forecast, by Product, 2016-2026
9.2.1. Quaternary Ammonium Compounds
9.2.2. Chlorine Compounds
9.2.3. Alcohols
9.2.4. Aldehydes
9.2.5. Phenolic Compounds
9.2.6. Hydrogen Peroxide
9.2.7. Iodine
9.2.8. Silver
9.2.9. Others
9.3.Market Value Forecast, by End-user, 2016-2026
9.3.1. Healthcare Providers
9.3.2. Commercial Users
9.3.3. Domestic Users
9.4.Market Value Forecast, by Country, 2016-2026
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5.Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
Chapter 10.Asia Pacific Antiseptic and Disinfectant Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast, by Product, 2016-2026
10.2.1. Quaternary Ammonium Compounds
10.2.2. Chlorine Compounds
10.2.3. Alcohols
10.2.4. Aldehydes
10.2.5. Phenolic Compounds
10.2.6. Hydrogen Peroxide
10.2.7. Iodine
10.2.8. Silver
10.2.9. Others
10.3.Market Value Forecast, by End-user, 2016-2026
10.3.1. Healthcare Providers
10.3.2. Commercial Users
10.3.3. Domestic Users
10.4. Market Value Forecast, by Country, 2016-2026
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5.Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country
Chapter 11.Latin America Antiseptic and Disinfectant Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016-2026
11.2.1. Quaternary Ammonium Compounds
11.2.2. Chlorine Compounds
11.2.3. Alcohols
11.2.4. Aldehydes
11.2.5. Phenolic Compounds
11.2.6. Hydrogen Peroxide
11.2.7. Iodine
11.2.8. Silver
11.2.9. Others
11.3.Market Value Forecast, by End-user, 2016-2026
11.3.1. Healthcare Providers
11.3.2. Commercial Users
11.3.3. Domestic Users
11.4.Market Value Forecast, by Country, 2016-2026
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country
Chapter 12.Middle East & Africa Antiseptic and Disinfectant Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016-2026
12.2.1. Quaternary Ammonium Compounds
12.2.2. Chlorine Compounds
12.2.3. Alcohols
12.2.4. Aldehydes
12.2.5. Phenolic Compounds
12.2.6. Hydrogen Peroxide
12.2.7. Iodine
12.2.8. Silver
12.2.9. Others
12.3.Market Value Forecast, by End-user, 2016-2026
12.3.1. Healthcare Providers
12.3.2. Commercial Users
12.3.3. Domestic Users
12.4.Market Value Forecast, by Country, 2016-2026
12.4.1. GCC countries
12.4.2. South Africa
12.4.3. Israel
12.4.4. Rest of Middle East & Africa
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country
Chapter 13.Competition Landscape
13.1.Market Player - Market Presence (2017)
13.1.1. Current Offerings
13.1.2. Strategy
13.2.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
13.2.1. Novartis AG
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Product Portfolio
13.2.1.3. SWOT Analysis
13.2.1.4. Financial Overview
13.2.1.5. Strategic Overview
13.2.2. 3M Company
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Product Portfolio
13.2.2.3. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. Johnson & Johnson
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Product Portfolio
13.2.3.3. SWOT Analysis
13.2.3.4. Financial Overview
13.2.3.5. Strategic Overview
13.2.4. STERIS plc
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Product Portfolio
13.2.4.3. SWOT Analysis
13.2.4.4. Financial Overview
13.2.4.5. Strategic Overview
13.2.5. Getinge Group
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Product Portfolio
13.2.5.3. SWOT Analysis
13.2.5.4. Financial Overview
13.2.5.5. Strategic Overview
13.2.6. Cardinal Health
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Product Portfolio
13.2.6.3. SWOT Analysis
13.2.6.4. Financial Overview
13.2.6.5. Strategic Overview
13.2.7. Becton, Dickinson And Company
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Product Portfolio
13.2.7.3. SWOT Analysis
13.2.7.4. Financial Overview
13.2.7.5. Strategic Overview
13.2.8. Whiteley Corporation
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Product Portfolio
13.2.8.3. SWOT Analysis
13.2.8.4. Financial Overview
13.2.8.5. Strategic Overview
13.2.9. Kimberly-Clark
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Product Portfolio
13.2.9.3. SWOT Analysis
13.2.9.4. Financial Overview
13.2.9.5. Strategic Overview
13.2.10. Others